TY  - CONF

T1  - 609 Restoring immune responsiveness in periphery and tumor with mRNA-4359, an mRNA-based therapy encoding PD-L1 and IDO1 peptides, plus pembrolizumab in checkpoint inhibitor resistant/refractory melanoma

JO  - Regular and Young Investigator Award Abstracts

UR  - https://doi.org/10.1136/jitc-2025-sitc2025.0609

PY  - 2025/11/04

AU  - Sarker D

AU  - Long G

AU  - Pinato DJ

AU  - Khattak A

AU  - Medina T

AU  - Karydis I

AU  - Middleton GW

AU  - Spiliopoulou P

AU  - Rohatgi A

AU  - Gutierrez M

AU  - Daud A et al

ED  - 

DO  - DOI: 10.1136/jitc-2025-sitc2025.0609

PB  - BMJ Publishing Group Ltd

SP  - A694

EP  - A694

Y2  - 2025/12/22

ER  -